Turner Syndrome
Cardiovascular·MeSH: Turner Syndrome
Prevalence
30.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| somatropin | Ascendis Pharma A/S (ASND) |
Frequently asked questions
How many drugs are in development for Turner Syndrome?
BioSniper tracks 1 drug in development for Turner Syndrome across 1 company.
How many clinical trials target Turner Syndrome?
There are 3 clinical trials targeting Turner Syndrome tracked by BioSniper.
What is the prevalence of Turner Syndrome?
The estimated prevalence of Turner Syndrome is approximately 30.0 per 100,000 population.
Deep-dive into Turner Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis